AISN Integrating AI in Stroke Neurorehabilitation
- Coordinator
- Universidad Miguel Hernandez De Elche, Spain
- Runs
- 1 December 2022 to 30 June 2027
- Status
- Running
- EU funding
- €5.9m
- Total cost
- €6.0m
- Partners
- 18 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057655
What the project is doing
In the project's own words, from its summary on CORDIS.
Health services are increasingly moving towards a treatment continuum aligned with the patient journey. This transition will critically depend on the successful deployment of trustworthy AI-enhanced technologies that are accurate, secure, and trusted. The AISN project will develop and validate operating procedures and guidelines for integrating AI in a healthcare continuum, focussing on post-stroke rehabilitation. AISN delivers a representative AI health platform built from integrating validated platforms for data acquisition and access, clinical interpretation, whole-brain simulation, clinically validated intervention delivery and optimization and model-based prediction.
The AISN integrated platform will be validated in the clinical context of rehabilitation in the outpatient and at-home phase and facilitate a concrete assessment of the fundamental ways in which AI-enhanced clinical decision-support will change the care pathway and the formulation of novel AI compatible treatment guidelines. AISN ensures an ethical approach by developing legal and ethical guidelines for the robust, fair, and trustworthy deployment of AI in health and validating acceptance and transparency of its solutions.
Building on the AISN platform, the project will test current standard operating procedures for integrating AI in health care and formulate and validate new ones where needed. The AISN guidelines and procedures will emphasize the evidence base and safety of clinical interventions, transparency, prognostics at varying time-scales, personalization of interventions, access to disease-specific information by clinicians, patients and their carers, and assure that the potential of AI is fully developed in the service of value-based medicine satisfying standards of security and safety.
We will go beyond currently available guidelines and frameworks by emphasizing explainability, AI tools with evolving performance, and the dynamic interaction between users and algorithms.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Miguel Hernandez De Elche | Elche | Spain | Coordinator |
| Universitat Wien | Wien | Austria | Participant |
| Ebrains | Bruxelles / Brussel | Belgium | Participant |
| Insel Gruppe AG | Bern | Switzerland | Associatedpartner |
| Les Hopitaux Universitaires De Geneve | Geneve 14 | Switzerland | Associatedpartner |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| Tp21 GmbH | Berlin | Germany | Participant |
| Eodyne Systems SL | Barcelona | Spain | Participant |
| Fundacio Privada per a La Recerca I La Docencia Sant Joan De Deu | Esplugues De Llobregat | Spain | Participant |
| Medtronic Iberica SA | Madrid | Spain | Participant |
| Parc Sanitari Sant Joan De Deu | Sant Boi De Llobregat | Spain | Third party |
| Centre hospitalier universitaire de Limoges | Limoges | France | Participant |
| Universite De Limoges | Limoges | France | Participant |
| San Camillo Irccs SRL | Venezia | Italy | Participant |
| Saddle Point Science Europe BV | Nijmegen | Netherlands | Participant |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Universitatea De Medicina Si Farmacie Iuliu Hatieganu Cluj-Napoca | Cluj-Napoca | Romania | Participant |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI